Caribou Biosciences is stopping work on its two remaining most cancers cell therapies and exploring strategic options for the enterprise. The transfer follows the CRISPR biotech firm’s failure to safe financing for its scientific trial plans.
The submit Caribou Bio’s Journey With Off-the-Shelf Cell Remedy Reaches the Finish of the Street appeared first on MedCity Information.
Discover the latest in health and fitness with Your Health 247. Get expert advice, workout routines, healthy recipes, and mental wellness tips to lead a healthier, happier life. Stay informed and empowered with us!
